지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.1
- 수록면
- 1 - 10 (10page)
이용수
초록· 키워드
오류제보하기
Background: Vaccines against coronavirus disease 2019 (COVID-19) are raising concerns about vaccine safety, particularly in the context of large-scale immunization. To address public concerns, we measured the baseline incidence rates of major conditions potentially related to vaccine-related adverse events (VAEs). We aimed to provide a basis for evaluating VAEs and verifying causality. Methods: Conditions of interest were selected from the US Vaccine Adverse Event Reporting System Table of Reportable Events and a recent report from a European consortium on vaccine surveillance. We used the National Health Insurance Service database in Korea to identify the monthly numbers of cases with these conditions. Data from January 2006 to June 2020 were included. Prediction models were constructed from the observed incidences using an autoregressive integrated moving average. We predicted the incidences of the conditions and their respective 95% confidence intervals (CIs) for January through December 2021. In addition, subgroup analysis for the expected vaccination population was conducted. Results: Mean values (95% CIs) of the predicted monthly incidence of vasovagal syncope, anaphylaxis, brachial neuritis, acute disseminated encephalomyelitis, Bell's palsy, Guillain-Barré syndrome, encephalopathy, optic neuritis, transverse myelitis, immune thrombocytopenic purpura, and systemic lupus erythematosus in 2021 were 23.89 (19.81–27.98), 4.72 (3.83–5.61), 57.62 (51.37–63.88), 0.03 (0.01–0.04), 8.58 (7.90–9.26), 0.26 (0.18–0.34), 2.13 (1.42–2.83), 1.65 (1.17–2.13), 0.19 (0.14–0.25), 0.75 (0.61–0.90), and 3.40 (2.79–4.01) cases per 100,000 respectively. The majority of the conditions showed an increasing trend with seasonal variations in their incidences. Conclusion: We measured the incidence of a total of 11 conditions that could potentially be associated with VAEs to predict the monthly incidence in 2021. In Korea, conditions that could potentially be related to VAEs occur on a regular basis, and an increasing trend is observed with seasonality.
목차
등록된 정보가 없습니다.
참고문헌 (20)
참고문헌 신청
Korea Centers for Disease Control & Prevention / 2021 / Free vaccination for All Citizens of COVID-19 to Return to Daily Life / Korea Centers for Disease Control & Prevention
Jung J / 2020 / Epidemiologic evaluation and risk communication regarding the recent reports of sudden death after influenza vaccination in the COVID-19 pandemic / J Korean Med Sci 35(41):e378
CDC COVID-19 Response TeamFood and Drug Administration / 2021 / Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020 / MMWR Morb Mortal Wkly Rep 70(2):46~51
Voysey M / 2021 / Safety and efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222)against SARS-CoV-2 : an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK / Lancet 397(10269):99~111
U.S. Department of Health and Human Services / Vaccine adverse event reporting system (VAERS) table of reportable events following vaccination
Jung J / 2020 / Epidemiologic evaluation and risk communication regarding the recent reports of sudden death after influenza vaccination in the COVID-19 pandemic / J Korean Med Sci 35(41):e378
CDC COVID-19 Response TeamFood and Drug Administration / 2021 / Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020 / MMWR Morb Mortal Wkly Rep 70(2):46~51
Voysey M / 2021 / Safety and efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222)against SARS-CoV-2 : an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK / Lancet 397(10269):99~111
U.S. Department of Health and Human Services / Vaccine adverse event reporting system (VAERS) table of reportable events following vaccination
이 논문의 저자 정보
최근 본 자료
댓글(0)
0